Frontiers in Gastroenterology is a multidisciplinary, open access and peer reviewed journal dedicated to improving health and promoting new research and advances in digestive disease. The journal aims to bridge the gap between scientific discoveries and clinical practical applications in gastroenterology and hepatology.

Led by Prof. Colm A O'Morain (Trinity College, Republic of Ireland), Frontiers in Gastroenterology aims to support better management and early diagnosis of gastrointestinal disease, and to promote evidence based and precision medicine. Topics include:

artificial intelligence
biomarkers
endoscopy
functional bowel disease
gastroenterology and cancer
gastrointestinal infection and the microbiome
gastrointestinal and liver disorders
hepatology
hepatobillary disease
inflammatory bowel disease
therapeutics
physiological measurements
preventative strategies.

Articles that advance the UN’s Sustainable Development Goals (SDGs), especially SDG 3: Good health and wellbeing, are particularly welcome.

Manuscripts without a fundamental basis in gastroenterology or related medical fields are not suitable for publication in this journal. Studies that do not provide a comprehensive understanding of the topic or lack a fundamental basis in the field of gastroenterology will not be considered.

Frontiers in Gastroenterology is committed to advancing developments in the field of gastroenterology by communicating scientific knowledge to researchers and the public alike, to pave the way for scientific breakthroughs and improve the lives of patients with digestive diseases.

Navigation group

Volumes

Real-world effectiveness of Sofosbuvir/Velpatasvir, Glecaprevir/Pibrentasvir, and Sofosbuvir/Velpatasvir/Voxilaprevir against genotype 3 HCV infection: a systematic review and meta-analysis